Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

More on CVS Caremark (CVS): Retail pharmacy sales rose 4.3% with higher drug costs and the...

  • Tuesday, November 6, 2012, 7:15 AM ET
    More on CVS Caremark (CVS): Retail pharmacy sales rose 4.3% with higher drug costs and the growth of the firm's Medicare Part D program contributing. The company raises and narrows its full-year guidance to $3.38-$3.41, from a prior range of $3.32-$3.38. (PR)
Other date
DJIA (DIA) S&P 500 (SPY)